Speaker Faculty

Alejandro Bertolet

Assistant Professor of Radiation Oncology

Cardiovasuclar Genetics

Andreas Kluge

General Manager

ABX-CRO

Anna Kulesza

Pharmaceutical Development and Regulatory Affairs Director

RegulaNova Sarl

Carlos Uribe

Clinical Nuclear Medicine Physics Leader

BC Cancer Agency

Christopher Leamon

Chief Scientific Officer

Fusion Pharmaceuticals

Corentin Warnier

Head of Chemistry

Trasis

Eftychia Koumarianou

Head of Pharmaco-Imaging & Molecular RadioTherapy Department

Oncodesign Service

Eirini Bournazou

Evaluations & Clinical Collaborations Lead, Oncology External Innovation

Bristol Myers Squibb

Friedmund Bachmann

Vice President Chemistry, Manufacturing, and Controls

OncoOne

Gareth Smith

VP Strategy

Imaginab

Gemma Mudd

Director - Medicinal Chemistry

Bicycle Therapeutics

Germo Gericke

Chief Medical Officer, EVP Research & Development

Ariceum Therapeutics

Gregory Mullen

Chief Operating Officer

Ariceum Therapeutics

Guillaume Potdevin

Associate Director, Team Lead Computer Vision and AI

AstraZeneca

Herman Steen

Chief Executive Officer

Cortalix BV

Izabela Rejdych

Principal Consultant

RegulaNova

James Beatty

Vice President of Development

PharmaLogic

Jan Lennart von Hacht

Project & Alliance Manager

3B Pharmaceuticals

Jan Van Bodegom

Chief MedicalOfficer

Coretag

Jarrod Longcor

Chief Operating Officer

Cellectar Biosciences Inc.

Jeevan Virk

Head of RLT

Novartis AG

Jeremy Paull

VP

Starpharma

Julia Brosch-Lenz

Medical Physicist

Technical University Munich

Kevin Machel

Product Manager

ITM Isotope Technologies Munich SE

Marc Hedrick

CEO

Plus Therapeutics

Maritina Rouchota

Partner

BIOEMTECH Laboratories

Matthias Friebe

Chief Technology Officer

Ratio Therapeutics

Matthias Paschke

Director

3B Pharmaceuticals

Munir Ghesani

Systems Chief, Nuclear Medicine

Icahn School of Medicine at Mount Sinai

Nicolas Bozovic

Director of Pharmaceutical Operations and Projects

OranoMed

Pat Donahue

Chief Executive Officer

Iotron Medical

Philip Huxley

Vice President - Oncology Research

Bicycle Therapeutics

Raphael ORTIZ

Chief Executive Officer, EMEA

Telix Innovations

Ruth Devenyns

Chief Executive Officer

Precirix

Ulrich Haupts

CSO

Navigo Proteins

Urs Hagemann

Head of Targeted Radiopharmaceuticals

Bayer

Wei Huang

Deputy Manager

Chengdu New Radiomedicine Technology